Nutrient quality
Sodium ascorbate partly buffers the ascorbic acid base. The moderate vitamin C serving is meaningful for routine supplementation.
A practical larger-pack chewable with a useful serving and partial buffering. Good value offsets, but does not remove, the carbohydrate and disclosure drawbacks.
How scoring worksA practical larger-pack chewable with a useful serving and partial buffering. Good value offsets, but does not remove, the carbohydrate and disclosure drawbacks.
How scoring works| $ 18.87 | ||
Vitacost | $ 20.43 |
A 500 mg vitamin C blend supports everyday antioxidant needs, collagen formation, and normal immune function. The mix of ascorbic acid and sodium ascorbate offers a middle ground between plain and fully buffered products.
Chewable tablets and several flavors can improve adherence for people who dislike capsules. The formula is less streamlined because each serving carries carbohydrate and the full excipient list is absent.
The larger bottle improves cost efficiency for ongoing use. Its best audience values flavor and convenience more than a minimalist label or specialized delivery system.
Sodium ascorbate partly buffers the ascorbic acid base. The moderate vitamin C serving is meaningful for routine supplementation.
All listed active amounts are disclosed without a proprietary blend. Complete directions and inactive-ingredient details remain incomplete.
The aggregate rating and its volume provide a favorable top-level signal. Missing experience details prevent assessment of repeated complaints or purpose-specific satisfaction.
The larger package is competitively valued for a partly buffered chewable. Incomplete additive detail limits a stronger conclusion.
A useful combined vitamin C serving provides antioxidant, immune, and collagen support in a convenient chewable format. Partial buffering from sodium ascorbate may improve comfort, though the product remains a narrow single-nutrient option.
The larger mixed-fruit chewable states the active amount and forms clearly. Added carbohydrates and incomplete excipient detail make it less streamlined than a simple capsule, while the supplied package provides good convenience value without changing its health contribution.
A practical vitamin C amount directly supports antioxidant protection and normal immune-cell function. Combining ascorbic acid with sodium ascorbate provides partial buffering in a convenient chewable form.
The formula supports one important immune pathway rather than offering broad defense coverage. Carbohydrate and missing stabilization details are the main drawbacks, especially for frequent use.
A 500 mg blend of ascorbic acid and sodium ascorbate provides a meaningful collagen cofactor with partial buffering. The chewable format is convenient, although its carbohydrates and incomplete excipient details add some uncertainty.
The formula focuses on collagen synthesis and antioxidant defense without hydration or barrier-lipid support. Useful depth in one pathway is paired with little goal-irrelevant active padding.
Vitamin C provides meaningful antioxidant support that may help regulate oxidative stress linked with inflammation. The blend of ascorbic acid and sodium ascorbate offers partial buffering at a useful amount.
The formula remains focused on one indirect pathway rather than directly targeting major inflammatory enzymes. Its simple design is easy to assess, although a chewable format may include non-active ingredients not fully described here.
Vitamin C offers only a limited connection to focused eye health. The principal relevant amounts appear substantial enough to contribute in practice.
Coverage is concentrated on ocular antioxidant defense. The remaining ascorbic acid may cause digestive discomfort in sensitive users.
| Ingredient | Amount per serving |
|---|---|
Calories | 10 Calorie(s) |
Total Carbohydrates | 2 Gram(s) |
Vitamin C (Ascorbic Acid, Sodium Ascorbate) | 500 mg |
Sodium | 35 mg |
The 500 mg serving combines acidic and buffered vitamin C forms for balanced everyday use. Chewable delivery is convenient, but the supplied facts do not establish advanced stabilization or full excipient purity. A favorable active-amount cost offsets the formulation uncertainty.